ADC
Beyond's analysis on ADC
- — Akeso’s 2026 interim results show record‑high drug sales and progress on its IO 2.0 strategy, advancing bispecific ADCs in oncology, immunology and Alzheimer’s
- — Akeso's B7‑H3 ADC AK157D1 gains Phase I clearance, adding a third differentiated candidate to its oncology pipeline
- — Henlius and Sandoz partner to co‑develop up to ten biosimilar mAb and ADC assets, aiming to accelerate global market access and revenue generation
- — Akeso advances its IO2.0/ADC2.0 strategy with first patient dosed in Phase II trial of AK146D1 combined with ivonescimab for breast cancer
- — GlycoNex initiates first-in-human Phase I trial of its glycan-targeted ADC GNX1021 in Japan
- — Akeso initiates first‑in‑human trial of its HER3‑targeted ADC combined with Ivonescimab in lung cancer, advancing its IO2.0+ADC2.0 pipeline
- — Mabwell's ESMO 2026 oral presentation of clinical data for its Nectin-4-targeting ADC 9MW2821 highlights potential progress in triple-negative breast cancer therapy and could affect oncology investment sentiment
- — CPHI & PMEC China 2026 success unlocks fresh investment and partnership prospects for Greater Bay Area and Asian pharma firms
- — Akeso initiates Phase II trial of a novel TROP2/Nectin-4 bispecific ADC combined with Ivonescimab, advancing its oncology pipeline in NSCLC
Recent news mentioning ADC
- — Broadcom vs Marvell: One of These AI Chip Stocks Is a Clear Winner
- — AMD’s Whole AI Story Has One Threat It Cannot Ignore: Broadcom
- — Nvidia’s Hugging Face Deal Is a Hedge against Broadcom’s Custom Silicon Threat
- — Broadcom vs. Nvidia: 1 Critical Metric Shows Which Artificial Intelligence (AI) Chipmaker Is the Better Buy After Earnings
- — With AI Revenue Set to Surge 400% Over the Next 2 Years, Broadcom Stock Looks Like a Buy on Recent Dip
- — Broadcom (AVGO) AI Revenue Soars, But Wall Street Wants More
- — Jim Cramer Says “Someone Must Know Something” About Broadcom Inc. (NASDAQ:AVGO)’s Post-Earnings Share Dip
- — 5-star analyst resets Broadcom stock price target
- — Broadcom Crushed Earnings and the Stock Fell Anyway. Investors Are Ignoring a $230 Billion Signal.
- — Zainspirowane życiem, napędzane przez AI: TCL na nowo definiuje codzienne doświadczenia podczas IFA 2026
- — Is AVGO Stock Poised for a Rebound After Broadcom's Strong Q3 Results?
- — Broadcom CEO Says AI Demand Could Be ‘Significantly’ Higher — But Land, Power, Chips and Substrates Are Holding Back Data Center Deployments